US Proposes Curbs on Investment in Chinese Biotech Firms
The Trump administration is seeking to restrict American investment in Chinese biotechnology companies, potentially complicating financial ties at a time when US drugmakers are increasingly turning to China for new medicines.
By Madison MullerBloomberg Technology
Read the full story
Originally published by Bloomberg Technology on Oct 22, 2026.
Comments
Sign in to join the discussion.